Stay updated on Balugrastim in Breast Cancer with Doxorubicin/Docetaxel Clinical Trial

Sign up to get notified when there's something new on the Balugrastim in Breast Cancer with Doxorubicin/Docetaxel Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Balugrastim in Breast Cancer with Doxorubicin/Docetaxel Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T23:37:36.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the page. Removed the notices about government funding lapse and operating status (previously shown as v3.4.1/v3.4.2).
    Difference
    0.4%
    Check dated 2026-02-11T10:24:09.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide funding notice is displayed and the page revision is updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T09:18:05.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle display and updated footer metadata to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and a new 'Revision: v3.4.0' (replacing the previous labels). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:44:17.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page. This is a minor metadata update and does not modify study details, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2026-01-14T01:49:33.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure link along with the Revision: v3.3.2 text were removed.
    Difference
    0.1%
    Check dated 2025-12-23T17:12:06.000Z thumbnail image

Stay in the know with updates to Balugrastim in Breast Cancer with Doxorubicin/Docetaxel Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Balugrastim in Breast Cancer with Doxorubicin/Docetaxel Clinical Trial page.